JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for ARDELYX, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare ESRD benefit and chronic kidney disease management

Health Issues

Issues related to medication affordability and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.